Rebalance’s Schwab Emerging Markets Equity ETF SCHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.3M Buy
2,298,258
+113,863
+5% +$4.07M 4.37% 7
2026
Q1
$72M Buy
2,184,395
+16,458
+0.8% +$562K 4.18% 7
2025
Q4
$71M Buy
2,167,937
+92,510
+4% +$3.08M 4.15% 7
2025
Q3
$69.3M Buy
2,075,427
+78,925
+4% +$2.49M 4.18% 7
2025
Q2
$60.2M Sell
1,996,502
-125,546
-6% -$3.55M 4.09% 8
2025
Q1
$58.5M Buy
2,122,048
+8,151
+0.4% +$223K 4.31% 9
2024
Q4
$56.3M Buy
2,113,897
+58,482
+3% +$1.65M 4.21% 9
2024
Q3
$60M Buy
2,055,415
+101,963
+5% +$2.76M 4.39% 9
2024
Q2
$51.9M Buy
1,953,452
+173,665
+10% +$4.53M 4.17% 9
2024
Q1
$44.9M Buy
1,779,787
+43,356
+2% +$1.07M 3.69% 9
2023
Q4
$43M Buy
1,736,431
+146,298
+9% +$3.52M 3.75% 9
2023
Q3
$38.1M Buy
1,590,133
+7,204
+0.5% +$178K 3.7% 9
2023
Q2
$39M Buy
1,582,929
+79,210
+5% +$1.94M 3.7% 9
2023
Q1
$36.9M Sell
1,503,719
-15,988
-1% -$396K 3.65% 11
2022
Q4
$36M Buy
+1,519,707
New +$35.4M 3.73% 11

Other funds holding SCHE

Rebalance's SCHE Position: Q2 2026 in Review

Rebalance increased its Schwab Emerging Markets Equity ETF (SCHE) stake by 5.2% in Q2 2026, buying an estimated $4.07M and bringing the position to 2,298,258 shares worth $83.3M. The position accounts for 4.37% of the portfolio, ranked #7.

Rebalance first reported a position in SCHE in Q4 2022 and has held it in 15 quarters since. 892 funds tracked by Wall St. Rank hold SCHE as of Q2 2026.

  • Rebalance held 2,298,258 shares of Schwab Emerging Markets Equity ETF worth $83.3M as of Q2 2026.
  • Rebalance bought 113,863 Schwab Emerging Markets Equity ETF shares in Q2 2026, an estimated $4.07M.
  • Schwab Emerging Markets Equity ETF made up 4.37% of Rebalance's portfolio in Q2 2026, its #7 holding.
  • Rebalance first reported a position in Schwab Emerging Markets Equity ETF in Q4 2022 and has held it in 15 quarters since.
  • 892 funds tracked by Wall St. Rank held Schwab Emerging Markets Equity ETF as of Q2 2026.

Based on Rebalance's 13F filing for Q2 2026, filed 16 Jul 2026.